April 28, 2022


———————————————
The NeurologyLive® team has been as busy as always bringing you the latest clinical news and research updates in neurology over the last month, including conducting several interviews with experts across a number of different and varying topics.

This month, the team was on-site in Seattle, Washington, for the 2022 American Academy of Neurology Annual Meeting, providing live coverage of sessions and presentations from the floor of the convention center. While there, the team conducted a variety of sit-down interviews with experts about hot button issues and topics at the annual meeting.

Among these included conversations about the associations between stroke and COVID-19 with Matthew Schindler, MD, PhD; SanBio’s investigational agent for traumatic brain injury with Peter J. McAllister, MD, FAAN; the details of an item-level analysis of aducanumab (Aduhelm; Biogen) with Sharon Cohen, MD, FRCPC; the paradigm shift in therapeutics for amyotrophic lateral sclerosis (ALS) with Matthew Kiernan, MBBS, PhD, DSc, FRACP, FAHMS; the priorities for research in migraine with Rashmi B. Halker-Singh, MD, FAAN, and Paul Mathew, MD, DNBPAS, FAAN, FAHS; and the long-term neurological trajectories observed in severe COVID-19 cases with Jennifer Frontera, MD.

Click through the videos to see and read more from each expert’s exclusive conversation with NeurologyLive® from AAN 2022.

Click here for more coverage of AAN 2022.